Browsing by Subject
Ara mostrant els elements 1-5 d 5
-
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate
(American Society of Clinical Oncology, 2023-11-10) -
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma
(Future Medicine, 2022-09)